The cost-effectiveness of genetic testing strategies for Lynch syndrome among newly diagnosed patients with colorectal cancer
about
sameAs
Cost-Effectiveness Analysis of Different Genetic Testing Strategies for Lynch Syndrome in TaiwanPublic health action in genomics is now needed beyond newborn screeningComparing universal Lynch syndrome tumor-screening programs to evaluate associations between implementation strategies and patient follow-through.Epidemiology matters: peering inside the "black box" in economic evaluations of genetic testingScreening for mismatch repair deficiency in colorectal cancer: data from three academic medical centers.Predictive model for high-frequency microsatellite instability in colorectal cancer patients over 50 years of age.The revised Bethesda guidelines: extent of utilization in a university hospital medical center with a cancer genetics programDirect-to-patient disclosure of results of mismatch repair screening for Lynch syndrome via electronic personal health record: a feasibility study.Evaluating genomic tests from bench to bedside: a practical frameworkCost-effectiveness and diagnostic effectiveness analyses of multiple algorithms for the diagnosis of Lynch syndrome.Preferences for outcomes associated with decisions to undergo or forgo genetic testing for Lynch syndrome.Communication and technology in genetic counseling for familial cancer.Applying public health screening criteria: how does universal newborn screening compare to universal tumor screening for Lynch syndrome in adults with colorectal cancer?Comparative effectiveness of screening strategies for Lynch syndrome.Concepts of 'personalization' in personalized medicine: implications for economic evaluation.A model-based assessment of the cost-utility of strategies to identify Lynch syndrome in early-onset colorectal cancer patients.The cost-effectiveness of returning incidental findings from next-generation genomic sequencing.Lynch syndrome patients' views of and preferences for return of results following whole exome sequencing.Economic analyses of genetic tests in personalized medicine: clinical utility first, then cost utility.Value of Genetic Testing for Hereditary Colorectal Cancer in a Probability-Based US Online SampleClinical characterization and mutation spectrum in Caribbean Hispanic families with Lynch syndrome.Universal tumor screening for Lynch syndrome: Assessment of the perspectives of patients with colorectal cancer regarding benefits and barriers.When is Genomic Testing Cost-Effective? Testing for Lynch Syndrome in Patients with Newly-Diagnosed Colorectal Cancer and Their Relatives.Stakeholder perspectives on implementing a universal Lynch syndrome screening program: a qualitative study of early barriers and facilitators.Clinical utility of family history for cancer screening and referral in primary care: a report from the Family Healthware Impact Trial.Economic evidence on identifying clinically actionable findings with whole-genome sequencing: a scoping reviewInitiation of universal tumor screening for Lynch syndrome in colorectal cancer patients as a model for the implementation of genetic information into clinical oncology practice.A Systematic Review of Health Economic Evaluations of Diagnostic Biomarkers.Hereditary cancer registries improve the care of patients with a genetic predisposition to cancer: contributions from the Dutch Lynch syndrome registryImplementing screening for Lynch syndrome among patients with newly diagnosed colorectal cancer: summary of a public health/clinical collaborative meeting.Underutilization of Lynch syndrome screening in a multisite study of patients with colorectal cancer.Which BRCA genetic testing programs are ready for implementation in health care? A systematic review of economic evaluations.Issues surrounding the health economic evaluation of genomic technologies.Implementation of routine screening for Lynch syndrome in university and safety-net health system settings: successes and challenges.Reflex testing for Lynch syndrome: if we build it, will they come? Lessons learned from the uptake of clinical genetics services by individuals with newly diagnosed colorectal cancer (CRC).Management strategies in Lynch syndrome and familial adenomatous polyposis: a national healthcare survey in Japan.Microsatellite instability and therapeutic consequences in colorectal cancer.Follow-up recommendations and risk-reduction initiatives for Lynch syndrome.Screening for Muir-Torre syndrome using mismatch repair protein immunohistochemistry of sebaceous neoplasms.Hereditary gynaecological malignancies: advances in screening and treatment.
P2860
Q26779546-592D504D-1A39-4695-986C-6D749DE28055Q26998734-AB2570A2-0374-4D0C-937F-A37E257228DEQ30587310-B8645073-DD16-48A6-B04A-BF7079AC2952Q33764223-6F7F6B76-4EED-4B6F-9D8C-942F468E0F6CQ33775296-73131699-4111-4C06-8C6C-0DCCD87EFDF3Q33775336-1F877727-F44F-4CE3-B5A0-F9E9E8E54A6EQ34380045-DE4E239A-48C1-43FE-9500-E3AEFDFE188FQ34437807-D263E66D-5CFF-4D34-880A-D0B97E7AE571Q34451291-740B88AE-0A44-4F87-85C1-809BB8236F52Q34543387-AD8231B3-1E04-46B2-9EFA-A3DE22059F68Q35168638-D328A769-44D2-4CEE-876B-506AD29646AEQ35212286-E824B7FE-4F3A-4662-A458-2D1EF4F174ADQ35469854-58A3F0FD-EEA2-4043-87E1-9904072FF20EQ35474031-4252131C-03EC-47DE-A875-95109CB6AD9DQ35575935-67AB9737-B76B-484E-A10D-3186A54416F9Q35596050-4F313438-0D14-4107-8CC7-C45AA34B350AQ35602902-E2D4A437-C8BF-42C5-952E-53E988FE7807Q35671138-2DDCEB1F-AC6C-4B8C-8D16-AB0E2C046554Q35681121-A8E2DA22-F10F-4031-9C45-839661FFCE95Q35850612-A5291140-3241-4E1D-9B31-96C7D4320D57Q36029438-70AFA3B5-1DDD-43A8-89C8-C92655C8B988Q36030785-08AE6D42-9273-4FB2-B35C-492834ED75EBQ36157315-26C3DD16-9B15-476F-B5E4-52FB26A8A258Q36171056-89142A7B-D440-45A4-8D0F-116F26DF888DQ36182632-4676E803-541E-4864-8121-25B84875661DQ36304418-85687D06-234D-427F-B225-8C5E47489584Q36494281-849794C5-B58E-492B-965A-D0B6CB2E92E4Q36541715-99A4ED1A-D2D4-42D7-8ABA-FC08CE792FA1Q36990149-3E012DC6-FDDD-4242-8EA1-CF60CF2D82ADQ37146388-C6ADA272-7A26-4A6C-917F-87F435EF36A8Q37374391-9405D83A-3036-42D1-BE96-D9AFF6508DDEQ37507366-C762107E-8641-4C3B-9FB8-F4851C59FFBDQ37541151-CFFAC2A4-A00A-4B9F-B2C9-2238B80E822EQ37561427-C2EE3F31-39C3-4962-B229-00B26FDE53F2Q37589534-C3F7EA57-F1E6-4C51-9CB0-79ECF12049F0Q37670683-B112E41A-D213-4A58-A35D-69176BEE932CQ38020733-683117AF-CF29-4C77-ABF4-E427E79F24B5Q38062023-14E65D12-0664-4E3A-87EB-616104208518Q38065071-C22957B1-A3A8-4069-A907-1E0243B12238Q38067433-31C9A485-4563-4CA4-96AA-886F7468FE81
P2860
The cost-effectiveness of genetic testing strategies for Lynch syndrome among newly diagnosed patients with colorectal cancer
description
scientific article published on 01 February 2010
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в січні 2009
@uk
name
The cost-effectiveness of gene ...... atients with colorectal cancer
@en
The cost-effectiveness of gene ...... atients with colorectal cancer
@nl
type
label
The cost-effectiveness of gene ...... atients with colorectal cancer
@en
The cost-effectiveness of gene ...... atients with colorectal cancer
@nl
prefLabel
The cost-effectiveness of gene ...... atients with colorectal cancer
@en
The cost-effectiveness of gene ...... atients with colorectal cancer
@nl
P2860
P1433
P1476
The cost-effectiveness of gene ...... atients with colorectal cancer
@en
P2093
Glenn E Palomaki
Heather Hampel
P2860
P2888
P304
P356
10.1097/GIM.0B013E3181CD666C
P407
P577
2010-02-01T00:00:00Z
P6179
1016727396